Does it improve the activity?
Faster. Safer. Cheaper. More accurate. More accessible. A candidate must produce a material improvement rather than simply attach AI to an existing product.
We invest where artificial intelligence is moving beyond possibility and becoming useful in the real world — improving health, expanding human capability, increasing safety, reducing scarcity, and helping essential systems work better.
Faster. Safer. Cheaper. More accurate. More accessible. A candidate must produce a material improvement rather than simply attach AI to an existing product.
We identify the end beneficiary—patients, workers, students, operators, families or communities—and ask whether the gain can be observed outside the pitch deck.
AI must create the advantage: superior economics, capability, defensibility or category redefinition. “AI exposure” by itself is not an investment thesis.
We look for areas where AI can meaningfully improve human outcomes—not simply create another layer of software.
We study the technology, economics, management, competitive advantages and real-world constraints that determine whether promising applications can scale.
We seek companies capable of translating technological progress into enduring human and economic value, while maintaining rigorous standards for valuation, financial strength and risk.